You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Early-Stage NSCLC

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Early-stage Non-small Cell Lung Cancer

Completed
  • Non-small Cell Lung Cancer
    • Alexandria, Egypt
    • +3 more
    Nov 21, 2022

    NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

    Recruiting
    • NSCLC
    • SBRT+LDRT
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Apr 2, 2023

    Non Small Cell Lung Cancer Trial in Hong Kong, Netherlands, Spain (Pulsed electric field treatment using the Aliya System)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Pulsed electric field treatment using the Aliya System
    • Sha Tin, Hong Kong
    • +3 more
    Jan 6, 2023

    Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)

    Active, not recruiting
    • Squamous Non-small Cell Lung Cancer
    • Nivolumab 10 MG/ML Intravenous Solution
    • Best Supportive Care
    • Imola, Bologna, Italy
    • +30 more
    Sep 30, 2022

    NSCLC Trial (Atezolizumab, Tiragolumab)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Apr 5, 2023

    Sarcopenia and Nutritional Status in Early-stage Non-small Cell

    Not yet recruiting
    • Sarcopenia
    • +2 more
    • Inbody 570
    • +2 more
    • Shanghai, Shanghai, China
      Huadong hospital, Fudan University
    Jan 27, 2022

    NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)

    Not yet recruiting
    • NSCLC, Stage III
    • Signatera ctDNA test
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Mar 13, 2023

    Adjuvant Therapy in Early Stage NSCLC With EGFR

    Recruiting
    • NSCLC, Stage I
    • +2 more
    • Surgeries
    • Peking, Beijing, China
    • +50 more
    Mar 31, 2021

    NSCLC, Stage IV Trial in Amsterdam, Leiden (18F-FDG PET-CT)

    Completed
    • NSCLC, Stage IV
    • 18F-FDG PET-CT
    • Amsterdam, Netherlands
    • +1 more
    Jan 25, 2021

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer Stage III
    • Nivolumab and Chemotherapy
    • +3 more
    • (no location specified)
    Aug 15, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    NSCLC Trial in Salvador, Belo Horizonte, São Paulo

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Salvador, Bahia, Brazil
      • +3 more
      Nov 28, 2022

      NSCLC, Stage III Trial in Beijing (Tislelizumab, Pemetrexed (Nonsquamous NSCLC) or Paclitaxel/Nab-paclitaxel(Squamous NSCLC),

      Recruiting
      • NSCLC, Stage III
      • Beijing, Beijing, China
        Beijing Tsinghua Chang Gung Hospital
      Nov 4, 2022

      NSCLC, Stage I Trial in Xi'an (Segmentectomy, Lobectomy)

      Enrolling by invitation
      • NSCLC, Stage I
      • Segmentectomy
      • Lobectomy
      • Xi'an, Shannxi, China
        The Second Affiliated Hospital of Air Force Medical University U
      Sep 7, 2023

      NSCLC Trial in Shanghai (VATS, Thoracotomy)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • VATS
      • Thoracotomy
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Apr 20, 2022

      NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

      Recruiting
      • NSCLC Stage IV
      • New York, New York
        NYU Langone Health
      Jan 11, 2023

      NSCLC, Stage I Trial in Tianjin (Osimertinib)

      Recruiting
      • NSCLC, Stage I
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute & Hospital
      Jan 6, 2023

      Standard of Care Lifestyle Support for Stage III NSCLC Patients

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Lifestyle advice
      • (no location specified)
      Aug 23, 2022

      NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Sugemalimab and Chemotherapy
      • Changsha, China
        Hunan Cancer Hospital
      Jul 7, 2023

      Neoadjuvant Immunotherapy in Early Stage NSCLC in China

      Recruiting
      • Immunotherapy
      • Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong General Hospital, Gua
      Feb 25, 2020

      Early Stage NSCLC, NSCLC Trial in Saint Louis (Computed tomography-guided stereotactic adaptive radiotherapy, ETHOS)

      Not yet recruiting
      • Early Stage Non-small Cell Lung Cancer
      • Non-small Cell Lung Cancer
      • Computed tomography-guided stereotactic adaptive radiotherapy
      • ETHOS
      • Saint Louis, Missouri
        Washington University School of Medicine
      Mar 14, 2023

      Colorectal Cancer Trial

      Completed
      • Colorectal Cancer
        • (no location specified)
        Nov 8, 2023

        Aspirin in Combination With Trametinib and Dabrafenib

        Not yet recruiting
        • NSCLC
        • +4 more
        • Combind asprin with Trametinib and Dabrafenib
        • (no location specified)
        Aug 4, 2023

        Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Stanford, California
          Stanford University
        Oct 27, 2022

        Omitting Clinical Target Volume in Radical Treatment of

        Not yet recruiting
        • Immunotherapy
        • +3 more
        • IMRT+adjuvant immunotherapy
        • (no location specified)
        Jun 9, 2023